Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Halothane-inhalation system for using atracurium in rats.

Y C Yang1, I J Chen, W H Yip

  • 1Department of Pharmacology, Kaohsiung Medical College, Taiwan, Republic of China.

Gaoxiong Yi Xue Ke Xue Za Zhi = the Kaohsiung Journal of Medical Sciences
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis.

NEJM evidence·2026
Same author

Validation of diagnosis codes for pleural diseases and procedure codes for relevant respiratory procedures in a healthcare database in Hong Kong: a single tertiary centre study.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same author

An improved method for isolation of photosystem II from marine alga Porphyra yezoensis Udea.

Indian journal of biochemistry & biophysics·2013
Same author

NO donor KMUP-1 improves hepatic ischemia-reperfusion and hypoxic cell injury by inhibiting oxidative stress and pro-inflammatory signaling.

International journal of immunopathology and pharmacology·2013
Same author

NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis.

Pulmonary pharmacology & therapeutics·2013
Same author

KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways.

International journal of immunopathology and pharmacology·2012

A novel inhalation anesthetic system using Polyethylene-glycol 400 (PEG 400) with halothane or isoflurane provides safe and effective anesthesia in rats. This technique supports the use of atracurium, a neuromuscular blocking agent, and shows potential for clinical trials.

Area of Science:

  • Veterinary Anesthesiology
  • Pharmacology
  • Drug Delivery Systems

Background:

  • Developing safe and effective inhalation anesthetic techniques is crucial for preclinical research.
  • Polyethylene-glycol 400 (PEG 400) can be utilized to create sustained-release drug delivery systems.
  • Atracurium is a novel neuromuscular blocking agent requiring precise anesthetic management.

Purpose of the Study:

  • To develop and evaluate a novel slow-releasing inhalation anesthetic system using PEG 400.
  • To assess the efficacy of this system with halothane and isoflurane for anesthesia in rats.
  • To determine the optimal anesthetic concentrations for use with atracurium.

Main Methods:

  • Rats were anesthetized using an inhalation system combining PEG 400 with either halothane or isoflurane.

Related Experiment Videos

  • Vaporized anesthetic concentrations were precisely controlled and monitored.
  • Anesthetic efficacy and safety were evaluated during the administration of atracurium.

    • Main Results:

    • The PEG 400 system successfully produced adequate anesthetic levels for rats.
    • Efficient concentrations were determined as 0.15% for halothane and 0.1% for isoflurane.
    • A safe and efficient anesthetic state was maintained throughout the experiments.

    Conclusions:

    • The PEG 400-based inhalation anesthetic system offers a safe and effective method for rodent anesthesia.
    • This technique is suitable for procedures involving neuromuscular blocking agents like atracurium.
    • The findings suggest potential applicability in future clinical trials.